Carroll B - Search Results

1

Tardive dyskinesia among patients using antipsychotic medications in customary clinical care in the United States.

Loughlin AM, Lin N, Abler V, Carroll B. Loughlin AM, et al. Among authors: carroll b. PLoS One. 2019 Jun 4;14(6):e0216044. doi: 10.1371/journal.pone.0216044. eCollection 2019. PLoS One. 2019. PMID: 31163035 Free PMC article.

2

Hospital utilization rates following antipsychotic dose reductions: implications for tardive dyskinesia.

Caroff SN, Mu F, Ayyagari R, Schilling T, Abler V, Carroll B. Caroff SN, et al. Among authors: carroll b. BMC Psychiatry. 2018 Sep 24;18(1):306. doi: 10.1186/s12888-018-1889-2. BMC Psychiatry. 2018. PMID: 30249218 Free PMC article.

3

Hospital utilization rates following antipsychotic dose reduction in mood disorders: implications for treatment of tardive dyskinesia.

Caroff SN, Mu F, Ayyagari R, Schilling T, Abler V, Carroll B. Caroff SN, et al. Among authors: carroll b. BMC Psychiatry. 2020 Jul 11;20(1):365. doi: 10.1186/s12888-020-02748-0. BMC Psychiatry. 2020. PMID: 32652964 Free PMC article.

4

Health Care Resource Utilization and Costs for Patients with Tardive Dyskinesia.

Carroll B, Irwin DE. Carroll B, et al. J Manag Care Spec Pharm. 2019 Jul;25(7):810-816. doi: 10.18553/jmcp.2019.25.7.810. J Manag Care Spec Pharm. 2019. PMID: 31232207 Free PMC article.

5

Effect of tardive dyskinesia on quality of life in patients with bipolar disorder, major depressive disorder, and schizophrenia.

McEvoy J, Gandhi SK, Rizio AA, Maher S, Kosinski M, Bjorner JB, Carroll B. McEvoy J, et al. Among authors: carroll b. Qual Life Res. 2019 Dec;28(12):3303-3312. doi: 10.1007/s11136-019-02269-8. Epub 2019 Aug 21. Qual Life Res. 2019. PMID: 31435866 Free PMC article.

6

The burden of tardive dyskinesia secondary to antipsychotic medication use among patients with mental disorders.

McEvoy J, Park T, Schilling T, Terasawa E, Ayyagari R, Carroll B. McEvoy J, et al. Among authors: carroll b. Curr Med Res Opin. 2019 Jul;35(7):1205-1214. doi: 10.1080/03007995.2019.1569871. Epub 2019 Feb 15. Curr Med Res Opin. 2019. PMID: 30638073

7

Pharmacological treatment of tardive dyskinesia: recent developments.

Caroff SN, Campbell EC, Carroll B. Caroff SN, et al. Among authors: carroll b. Expert Rev Neurother. 2017 Sep;17(9):871-881. doi: 10.1080/14737175.2017.1358616. Epub 2017 Jul 31. Expert Rev Neurother. 2017. PMID: 28727483 Review.

8

Deutetrabenazine for tardive dyskinesia and chorea associated with Huntington's disease: a review of clinical trial data.

Claassen DO, Philbin M, Carroll B. Claassen DO, et al. Among authors: carroll b. Expert Opin Pharmacother. 2019 Dec;20(18):2209-2221. doi: 10.1080/14656566.2019.1674281. Epub 2019 Oct 15. Expert Opin Pharmacother. 2019. PMID: 31613641 Review.

9

Association of antipsychotic treatment switching in patients with schizophrenia, bipolar, and major depressive disorders.

Ayyagari R, Thomason D, Mu F, Philbin M, Carroll B. Ayyagari R, et al. Among authors: carroll b. J Med Econ. 2020 Feb;23(2):204-212. doi: 10.1080/13696998.2019.1685818. Epub 2019 Nov 26. J Med Econ. 2020. PMID: 31663802 Free article.

10

Risk assessment and prediction of TD incidence in psychiatric patients taking concomitant antipsychotics: a retrospective data analysis.

Patterson-Lomba O, Ayyagari R, Carroll B. Patterson-Lomba O, et al. Among authors: carroll b. BMC Neurol. 2019 Jul 20;19(1):174. doi: 10.1186/s12883-019-1385-4. BMC Neurol. 2019. PMID: 31325958 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,040 results

Search Page

Filters